Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based Chemotherapy
Clinical trial NCT02780687 · COMPLETED
Trial details
- NCT number
- NCT02780687
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-09
- Primary completion
- 2018-09-24
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.